作者
MAE Van der Kaaij, J van Echten-Arends, Natacha Heutte, Paul Meijnders, Edwige Abeilard-Lemoisson, Michele Spina, EC Moser, Anouk Allgeier, Bart Meulemans, PJ Lugtenburg, BMP Aleman, EM Noordijk, Christophe Fermé, Jose Thomas, Aspasia Stamatoullas, Christophe Fruchart, Houchingue Eghbali, Pauline Brice, WGJM Smit, Catherine Sebban, JK Doorduijn, JM Roesink, Isabelle Gaillard, Bertrand Coiffier, MLM Lybeert, O Casasnovas, Marc André, JMM Raemaekers, Michel Henry-Amar, JC Kluin-Nelemans
发表日期
2014/3/1
期刊
Human Reproduction
卷号
29
期号
3
页码范围
525-533
出版商
Oxford University Press
简介
STUDY QUESTION
How does the successful cryopreservation of semen affect the odds of post-treatment fatherhood among Hodgkin lymphoma (HL) survivors?
SUMMARY ANSWER
Among 334 survivors who wanted to have children, the availability of cryopreserved semen doubled the odds of post-treatment fatherhood.
WHAT IS KNOWN ALREADY
Cryopreservation of semen is the easiest, safest and most accessible way to safeguard fertility in male patients facing cancer treatment. Little is known about what proportion of patients achieve successful semen cryopreservation. To our knowledge, neither the factors which influence the occurrence of semen cryopreservation nor the rates of fatherhood after semen has been cryopreserved have been analysed before.
STUDY DESIGN, SIZE, DURATION
This is a cohort study with nested …
学术搜索中的文章
MAE Van der Kaaij, J van Echten-Arends, N Heutte… - Human Reproduction, 2014